decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
seed logo
FAQs NIH Staff Contact & Help

DermaXon

DermaXon targets the brain-skin connection to discover and develop novel therapeutic strategies to treat life-threatening diseases and disorders such as pain, pruritus and genetic disorders of skin keratinization. The company core technology is based on the design and development of small molecules modulating multiple targets or inhibiting the degradation of endogenous molecules exhibiting polypharmacology. This polypharmacological approaches aim to understand and optimize the unknown off-targets activities for existing small molecules such as cannabinoids or retinoic acid. DermaXon uses medicinal chemistry, molecular biology and RNA sequencing to characterize and identify synergies and overlaps between biological signaling pathways modulated by small molecules.
Contact Name:
Fanny Astruc Diaz
Contact Email:
[email protected]
City, State – Congressional District: Missoula,
MT
–
At-Large
Technology: Drug
Funding: Aging (NIA), Arthritis, Musculoskeletal, and Skin (NIAMS), Neurological Disorders and Stroke (NINDS), Translational Sciences (NCATS)
NIH Projects: NIH RePorter for DermaXon
Sponsored Event(s): BIO | 2020 , BIO | 2024
National Institutes of Health
Bethesda, MD 20892

Stay in the Loop

Subscribe to our mailing list for updates on deadlines and important information.

Site Map

Fraud, Waste and Abuse

HHS Vulnerability Disclosure | Technical Issues: E-mail OER Webmaster